CompoAtlas

Estro-Mend

Natural health product licensed in Canada

Licence holder
Douglas Laboratories Canada
NPN or DIN-HM
80032913
Status
Active licence
Licence date
18 June 2012
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Schisandra chinensis

Source : fruits et graines

Potency : 0.9 % Schisandrins

80 mgNot calculated
Pueraria montana var. lobata

Source : Racine

50 mgNot calculated
Glycine max

Source : Fève de soya

Potency : 11.31 mg ÉAI Genistein/genistin compound

75 mgNot calculated
Actaea racemosa

Source : Racine

20 mgNot calculated

Non-medicinal ingredients

Stéarate de magnésium, cellulose, Silice, Phosphate de dicalcium dihydrate, Gélatine

PopulationAgeQuantity per servingFrequency
AdultesNot specified3 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Traditionally used in Herbal Medicine to help relieve premenstrual symptoms. Helps relieve symptoms associated with menopause. Black cohosh used in Herbal Medicine to help relieve the pain associated with menstruation.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80032913

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line